Allergan Alphagan exclusivity threatened
Executive Summary
Allergan expects an expedited appeal in patent infringement suit against Alcon over glaucoma agent Alphagan could be heard before the end of the year, prior to generic approvals. Federal Circuit Court of Appeal grants Alcon's motion for summary judgment. Allergan does not expect an ANDA for generic brimonidine tartrate ophthalmic solution until the first quarter 2003...